Nifty

:

11247.55

Sensex

:

38067.93

25.15 (0.22%)
94.71 (0.25%)

Login

Nifty
Sensex

:
:

11247.55
38067.93

25.15 (0.22%)
94.71 (0.25%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

76/99

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

356.15

30-Sep-2020

Open
High
Low
Previous Close

363.00
368.00
355.00
365.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

256767
924.04
379.00
158.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,242.23
22.67
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,215.70
0.22%
3.81

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.57
6.22
7.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.85
5.07
5.26

PAT CAGR (%)

10 Years
5 Years
3 Years

4.79
7.33
11.45

P:E (Median)

8 Years
5 Years
3 Years

19.40
20.73
19.56

P:BV (Average)

8 Years
5 Years
3 Years

2.93
3.06
2.79

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.73
13.10
12.59

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 306.09 336.96 -9.16% 331.05 269.78 22.71% 317.91 252.34 25.98% 345.17 268.06 28.77%
Expenses 204.10 263.25 -22.47% 304.19 227.05 33.97% 234.72 198.66 18.15% 271.44 215.07 26.21%
EBITDA 101.99 73.70 38.39% 26.86 42.73 -37.14% 83.19 53.68 54.97% 73.72 52.98 39.15%
EBIDTM 33.32% 21.87% -0.29% 15.84% 26.17% 21.27% 21.36% 19.77%
Other Income 27.97 9.78 185.99% 42.45 14.09 201.28% 31.82 14.01 127.12% 25.20 15.20 65.79%
Interest 0.75 0.81 -7.41% 0.99 0.35 182.86% 0.80 0.34 135.29% 0.82 0.32 156.25%
Depreciation 9.41 9.34 0.75% 9.30 7.87 18.17% 9.18 7.48 22.73% 9.55 9.00 6.11%
PBT 119.79 73.34 63.34% 59.02 44.63 32.24% 104.56 59.87 74.65% 88.55 58.86 50.44%
Tax 29.17 21.06 38.51% 0.53 10.96 -95.16% 31.23 16.15 93.37% 25.87 15.77 64.05%
PAT 90.63 52.28 73.36% 58.49 33.66 73.77% 73.33 43.71 67.76% 62.68 43.09 45.46%
PATM 29.61% 15.52% 2.87% 12.48% 23.07% 17.32% 18.16% 16.08%
EPS 5.30 3.06 73.20% 3.42 1.97 73.60% 4.29 2.56 67.58% 3.67 2.52 45.63%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 308.18 343.52 -10.29% 333.33 270.67 23.15% 321.22 256.17 25.39% 346.12 273.82 26.40%
Expenses 204.60 265.04 -22.80% 304.04 227.62 33.57% 236.40 199.68 18.39% 272.25 216.45 25.78%
EBITDA 103.58 78.48 31.98% 29.29 43.05 -31.96% 84.82 56.49 50.15% 73.87 57.36 28.78%
EBIDTM 33.61% 22.84% 14.01% 15.90% 26.41% 22.05% 21.34% 20.95%
Other Income 27.97 9.79 185.70% 37.76 13.92 171.26% 31.03 13.98 121.96% 16.90 8.69 94.48%
Interest 0.75 0.81 -7.41% 0.99 0.36 175.00% 0.79 0.35 125.71% 0.82 0.32 156.25%
Depreciation 9.44 9.36 0.85% 9.32 7.90 17.97% 9.20 7.51 22.50% 9.57 9.03 5.98%
PBT 121.36 78.09 55.41% 56.73 47.61 19.16% 105.77 62.62 68.91% 80.38 56.70 41.76%
Tax 29.44 21.73 35.48% 0.86 11.21 -92.33% 31.51 16.54 90.51% 25.97 16.45 57.87%
PAT 91.92 56.36 63.09% 55.88 36.39 53.56% 74.25 46.08 61.13% 54.41 40.25 35.18%
PATM 29.83% 16.41% 7.11% 13.44% 23.12% 17.99% 15.72% 14.70%
EPS 5.38 3.30 63.03% 3.27 2.13 53.52% 4.34 2.69 61.34% 3.18 2.35 35.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,300.22 1,331.09 1,075.87 1,062.20 1,008.91 986.81 877.65 837.02 764.60 699.24 700.36 Net Sales Growth 15.36% 23.72% 1.29% 5.28% 2.24% 12.44% 4.85% 9.47% 9.35% -0.16% Cost Of Goods Sold 790.99 424.53 344.49 349.98 338.09 355.07 266.17 261.14 252.75 231.59 247.61 Gross Profit 509.23 906.56 731.39 712.22 670.81 631.74 611.48 575.88 511.84 467.65 452.75 GP Margin 39.17% 68.11% 67.98% 67.05% 66.49% 64.02% 69.67% 68.80% 66.94% 66.88% 64.65% Total Expenditure 1,014.45 1,047.51 855.83 843.10 766.96 759.85 680.92 633.28 582.11 538.41 537.01 Power & Fuel Cost - 27.38 24.60 21.98 21.52 23.12 20.15 18.42 16.83 13.75 12.68 % Of Sales - 2.06% 2.29% 2.07% 2.13% 2.34% 2.30% 2.20% 2.20% 1.97% 1.81% Employee Cost - 276.18 224.27 215.47 189.93 174.53 136.24 120.74 106.43 98.27 84.91 % Of Sales - 20.75% 20.85% 20.29% 18.83% 17.69% 15.52% 14.42% 13.92% 14.05% 12.12% Manufacturing Exp. - 61.09 62.19 58.70 49.34 36.39 97.19 88.58 74.64 70.17 67.02 % Of Sales - 4.59% 5.78% 5.53% 4.89% 3.69% 11.07% 10.58% 9.76% 10.04% 9.57% General & Admin Exp. - 57.18 58.56 60.53 52.70 49.55 41.11 35.66 34.08 33.55 31.52 % Of Sales - 4.30% 5.44% 5.70% 5.22% 5.02% 4.68% 4.26% 4.46% 4.80% 4.50% Selling & Distn. Exp. - 94.70 78.92 75.96 64.36 57.73 64.96 58.43 56.15 55.44 55.12 % Of Sales - 7.11% 7.34% 7.15% 6.38% 5.85% 7.40% 6.98% 7.34% 7.93% 7.87% Miscellaneous Exp. - 106.45 62.82 60.47 50.99 63.47 55.10 50.31 41.23 35.64 55.12 % Of Sales - 8.00% 5.84% 5.69% 5.05% 6.43% 6.28% 6.01% 5.39% 5.10% 5.45% EBITDA 285.76 283.58 220.04 219.10 241.95 226.96 196.73 203.74 182.49 160.83 163.35 EBITDA Margin 21.98% 21.30% 20.45% 20.63% 23.98% 23.00% 22.42% 24.34% 23.87% 23.00% 23.32% Other Income 127.44 82.66 54.80 51.25 49.65 39.98 44.38 40.81 47.60 28.72 27.84 Interest 3.36 3.41 1.43 1.40 1.41 1.40 1.75 3.01 1.51 1.32 1.34 Depreciation 37.44 37.36 33.14 35.04 34.52 33.61 38.50 24.54 27.51 18.05 16.99 PBT 371.92 325.46 240.27 233.91 255.67 231.94 200.85 216.99 201.06 170.18 172.87 Tax 86.80 78.68 64.76 65.59 62.72 63.03 54.94 82.57 42.72 37.49 24.12 Tax Rate 23.34% 24.18% 27.41% 28.04% 25.11% 27.18% 27.35% 38.05% 21.25% 22.03% 13.95% PAT 285.13 246.78 171.54 168.31 187.07 168.90 145.91 134.42 158.33 132.69 148.75 PAT before Minority Interest 285.13 246.78 171.54 168.31 187.07 168.90 145.91 134.42 158.33 132.69 148.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.93% 18.54% 15.94% 15.85% 18.54% 17.12% 16.63% 16.06% 20.71% 18.98% 21.24% PAT Growth 65.06% 43.86% 1.92% -10.03% 10.76% 15.76% 8.55% -15.10% 19.32% -10.80% EPS 16.67 14.43 10.03 9.84 10.94 9.88 8.53 7.86 9.26 7.76 8.70

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,308.85 1,344.19 1,090.70 1,075.07 1,013.87 994.32 889.31 845.85 772.83 710.54 711.67 Net Sales Growth 14.39% 23.24% 1.45% 6.04% 1.97% 11.81% 5.14% 9.45% 8.77% -0.16% Cost Of Goods Sold 4,936.70 425.72 345.14 352.08 339.05 357.93 272.91 266.16 311.11 237.54 253.93 Gross Profit -3,627.85 918.46 745.56 722.99 674.81 636.38 616.40 579.69 461.71 473.00 457.75 GP Margin -277.18% 68.33% 68.36% 67.25% 66.56% 64.00% 69.31% 68.53% 59.74% 66.57% 64.32% Total Expenditure 1,017.29 1,051.25 859.68 848.38 770.40 765.58 690.76 641.47 591.97 547.15 545.76 Power & Fuel Cost - 27.40 24.61 22.00 21.55 23.14 20.18 18.45 16.85 13.77 12.73 % Of Sales - 2.04% 2.26% 2.05% 2.13% 2.33% 2.27% 2.18% 2.18% 1.94% 1.79% Employee Cost - 277.48 225.57 216.67 191.08 175.76 137.58 122.05 107.52 99.02 85.57 % Of Sales - 20.64% 20.68% 20.15% 18.85% 17.68% 15.47% 14.43% 13.91% 13.94% 12.02% Manufacturing Exp. - 61.14 62.25 58.77 49.40 36.44 97.27 88.65 22.88 70.20 67.06 % Of Sales - 4.55% 5.71% 5.47% 4.87% 3.66% 10.94% 10.48% 2.96% 9.88% 9.42% General & Admin Exp. - 58.06 59.45 61.55 53.35 49.97 41.43 35.99 34.32 33.79 31.76 % Of Sales - 4.32% 5.45% 5.73% 5.26% 5.03% 4.66% 4.25% 4.44% 4.76% 4.46% Selling & Distn. Exp. - 94.70 78.92 75.96 64.36 57.73 64.96 58.43 56.15 55.45 55.12 % Of Sales - 7.05% 7.24% 7.07% 6.35% 5.81% 7.30% 6.91% 7.27% 7.80% 7.75% Miscellaneous Exp. - 106.74 63.73 61.35 51.61 64.61 56.43 51.73 43.13 37.36 55.12 % Of Sales - 7.94% 5.84% 5.71% 5.09% 6.50% 6.35% 6.12% 5.58% 5.26% 5.56% EBITDA 291.56 292.94 231.02 226.69 243.47 228.74 198.55 204.38 180.86 163.39 165.91 EBITDA Margin 22.28% 21.79% 21.18% 21.09% 24.01% 23.00% 22.33% 24.16% 23.40% 23.00% 23.31% Other Income 113.66 68.90 43.47 50.96 50.22 39.00 45.72 42.00 46.36 28.65 28.25 Interest 3.35 3.42 1.44 1.40 1.41 1.40 1.81 3.10 1.60 1.41 1.44 Depreciation 37.53 37.46 33.24 35.14 34.62 33.73 38.81 24.91 27.90 18.43 17.36 PBT 364.24 320.97 239.80 241.11 257.65 232.62 203.65 218.36 197.72 172.20 175.37 Tax 87.78 80.08 66.85 67.12 63.30 63.48 55.51 83.04 42.55 38.11 24.48 Tax Rate 24.10% 24.95% 28.01% 27.84% 25.14% 27.29% 27.26% 38.03% 21.52% 22.13% 13.96% PAT 276.46 240.89 171.85 173.99 188.47 169.14 148.15 135.32 155.17 134.09 150.89 PAT before Minority Interest 276.46 240.89 171.85 173.99 188.47 169.14 148.15 135.32 155.17 134.09 150.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.12% 17.92% 15.76% 16.18% 18.59% 17.01% 16.66% 16.00% 20.08% 18.87% 21.20% PAT Growth 54.38% 40.17% -1.23% -7.68% 11.43% 14.17% 9.48% -12.79% 15.72% -11.13% EPS 16.17 14.09 10.05 10.17 11.02 9.89 8.66 7.91 9.07 7.84 8.82

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 929.59 840.49 779.71 688.04 612.13 Share Capital 17.10 17.52 17.52 17.86 17.86 17.86 17.86 18.16 18.37 18.54 Total Reserves 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 911.72 822.63 761.54 669.67 593.59 Non-Current Liabilities 314.62 229.17 211.41 216.67 19.93 24.24 31.17 31.27 29.85 29.04 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.34 0.49 0.60 0.69 0.79 0.90 1.07 1.24 1.45 1.73 Long Term Provisions 295.78 213.96 194.12 198.60 0.50 0.56 0.00 0.00 0.00 2.20 Current Liabilities 562.37 494.21 476.08 387.41 162.11 185.73 192.61 151.15 135.33 120.27 Trade Payables 117.54 77.20 96.95 74.66 82.30 86.26 79.38 59.76 56.45 44.79 Other Current Liabilities 79.53 60.88 66.76 63.10 49.58 36.28 42.00 35.42 29.41 29.06 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 365.29 356.13 312.37 249.65 30.24 63.19 71.23 55.97 49.47 46.43 Total Liabilities 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 1,139.56 1,064.27 962.13 853.22 761.44 Net Block 669.77 678.47 669.75 674.50 670.89 381.37 272.13 276.55 280.02 271.78 Gross Block 840.73 813.68 772.29 742.10 704.26 613.76 454.57 437.17 414.16 389.17 Accumulated Depreciation 170.96 135.21 102.53 67.61 33.36 232.39 182.43 160.61 134.14 117.38 Non Current Assets 1,177.74 1,109.97 973.09 954.70 738.52 640.95 613.60 551.96 411.40 317.87 Capital Work in Progress 23.85 12.38 12.84 6.32 19.92 28.80 18.10 7.22 10.72 10.18 Non Current Investment 162.53 179.33 74.40 54.82 39.76 223.12 193.32 251.55 102.59 14.34 Long Term Loans & Adv. 320.83 239.08 215.28 218.46 7.70 6.76 128.71 15.13 17.41 19.42 Other Non Current Assets 0.75 0.71 0.81 0.60 0.25 0.90 1.33 1.51 0.65 2.15 Current Assets 1,241.06 1,046.45 976.80 913.10 520.05 498.17 450.20 409.66 441.28 443.51 Current Investments 502.24 405.93 397.16 436.53 285.41 272.49 229.90 170.91 243.92 248.86 Inventories 209.49 172.73 159.65 136.22 130.24 121.53 100.59 97.45 101.03 95.85 Sundry Debtors 124.19 83.52 76.71 77.46 64.03 60.70 60.82 44.76 40.69 39.60 Cash & Bank 28.96 15.70 21.12 23.02 13.50 11.66 21.25 34.90 13.42 16.05 Other Current Assets 376.17 11.01 10.51 9.42 26.88 31.79 37.63 61.64 42.22 43.16 Short Term Loans & Adv. 349.81 357.56 311.65 230.44 20.30 16.15 29.55 50.28 36.21 40.86 Net Current Assets 678.69 552.24 500.72 525.69 357.93 312.44 257.59 258.51 305.95 323.24 Total Assets 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57 1,139.55 1,064.27 962.12 853.22 761.44

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 936.38 845.30 784.24 695.42 616.39 Share Capital 17.10 17.52 17.52 17.86 17.86 17.86 17.86 18.16 18.37 18.54 Total Reserves 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 918.52 827.43 766.08 677.05 597.86 Non-Current Liabilities 314.62 229.17 211.41 216.67 19.93 24.06 30.97 31.32 30.24 29.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.56 0.77 Unsecured Loans 0.34 0.49 0.60 0.69 0.79 0.90 1.07 1.24 1.45 1.73 Long Term Provisions 295.78 213.96 194.12 198.60 0.50 0.56 0.00 0.00 0.00 2.20 Current Liabilities 564.62 497.43 480.07 389.40 163.42 187.97 195.69 153.97 139.01 123.45 Trade Payables 117.86 77.61 97.32 75.10 82.59 87.17 80.05 61.04 57.64 45.90 Other Current Liabilities 80.06 61.67 68.78 64.11 50.16 36.61 42.87 35.98 30.09 29.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 1.00 1.11 1.14 1.29 1.27 Short Term Provisions 366.69 358.15 313.97 250.19 30.67 63.19 71.66 55.81 49.99 46.68 Total Liabilities 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 1,148.41 1,071.96 969.53 864.67 769.43 Net Block 673.50 682.19 673.64 678.05 675.16 393.04 284.40 289.19 293.04 276.74 Gross Block 844.97 817.80 776.49 745.84 708.81 629.67 470.42 453.02 430.01 396.15 Accumulated Depreciation 171.47 135.61 102.84 67.79 33.65 236.62 186.02 163.82 136.96 119.41 Non Current Assets 1,181.25 1,113.46 976.64 957.93 742.46 646.27 619.47 558.20 418.02 322.50 Capital Work in Progress 23.85 12.38 12.84 6.32 19.92 28.80 18.10 7.22 10.72 10.18 Non Current Investment 162.31 179.11 74.07 54.49 39.43 216.72 186.92 245.15 96.20 14.01 Long Term Loans & Adv. 320.83 239.08 215.28 218.46 7.70 6.37 128.71 15.13 17.41 19.42 Other Non Current Assets 0.75 0.71 0.81 0.60 0.25 1.33 1.33 1.51 0.65 2.15 Current Assets 1,245.41 1,058.38 990.94 918.34 523.36 502.13 452.03 410.83 446.10 446.88 Current Investments 502.24 405.93 397.16 436.53 285.41 272.49 229.90 170.91 243.92 248.86 Inventories 209.96 173.79 160.49 137.16 130.91 123.22 103.00 99.71 102.92 97.42 Sundry Debtors 123.74 87.53 81.66 76.06 61.94 61.04 59.36 43.23 41.97 40.75 Cash & Bank 32.32 21.26 29.30 28.47 18.02 14.95 23.43 36.50 16.78 17.76 Other Current Assets 377.15 11.32 10.68 9.68 27.10 30.44 36.33 60.49 40.52 42.09 Short Term Loans & Adv. 350.34 358.56 311.65 230.44 20.36 14.77 28.18 48.89 34.66 39.71 Net Current Assets 680.79 560.94 510.87 528.94 359.94 314.16 256.33 256.86 307.09 323.43 Total Assets 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82 1,148.40 1,071.97 969.53 864.66 769.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 239.04 103.79 147.76 153.09 171.09 126.56 148.82 149.05 142.53 118.68 PBT 325.46 240.27 233.91 255.67 231.94 200.85 216.99 201.06 170.18 172.87 Adjustment 8.36 -13.54 -1.86 -11.07 0.24 -1.54 -7.41 -16.65 -3.00 0.77 Changes in Working Capital -11.00 -51.34 -16.54 -18.76 -5.75 -10.77 7.39 1.86 9.22 -20.62 Cash after chg. in Working capital 322.82 175.38 215.50 225.84 226.42 188.54 216.98 186.26 176.40 153.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -83.78 -71.60 -67.75 -69.78 -55.33 -61.98 -68.16 -37.22 -33.87 -34.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -2.97 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -84.80 -109.30 20.15 -143.55 -72.76 -88.89 -55.38 -105.08 -108.62 -30.36 Net Fixed Assets -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 -28.28 -19.51 -25.53 -17.54 Net Investments -79.51 -113.70 19.79 -166.18 170.44 -72.39 -0.76 -75.95 -83.31 -33.71 Others 33.23 45.33 37.07 46.87 -161.58 153.39 -26.34 -9.62 0.22 20.89 Cash from Financing Activity -142.00 -0.07 -169.43 0.35 -96.98 -47.47 -74.93 -62.28 -57.66 -57.35 Net Cash Inflow / Outflow 12.24 -5.58 -1.53 9.90 1.36 -9.80 18.51 -18.30 -23.75 30.97 Opening Cash & Equivalents 14.36 19.94 21.66 11.74 10.58 21.08 2.57 20.87 44.62 13.65 Closing Cash & Equivalent 26.52 14.36 19.94 21.66 11.74 11.28 21.08 2.57 20.87 44.62

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 250.38 112.43 149.84 154.49 174.30 127.64 149.72 149.94 144.33 120.74 PBT 319.95 237.75 240.63 257.71 232.15 203.65 218.36 197.72 172.20 175.37 Adjustment 22.58 -2.95 0.39 -10.88 2.41 -1.40 -7.67 -14.20 -2.62 1.31 Changes in Working Capital -7.77 -48.30 -23.24 -19.23 -4.54 -11.78 7.09 4.14 9.01 -20.98 Cash after chg. in Working capital 334.77 186.49 217.78 227.60 230.02 190.48 217.79 187.66 178.59 155.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -84.39 -74.06 -67.94 -70.14 -55.73 -62.84 -68.07 -37.72 -34.26 -34.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -2.97 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -98.35 -120.33 20.11 -143.55 -73.05 -88.57 -55.38 -107.18 -108.25 -33.00 Net Fixed Assets -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 -28.28 -19.51 -25.53 -17.54 Net Investments -79.51 -113.70 19.79 -166.18 170.44 -72.39 -0.76 -75.95 -83.31 -33.71 Others 19.68 34.30 37.03 46.87 -161.87 153.71 -26.34 -11.72 0.59 18.25 Cash from Financing Activity -142.00 -0.07 -169.43 0.35 -96.98 -47.76 -75.25 -62.83 -58.18 -57.51 Net Cash Inflow / Outflow 10.03 -7.96 0.52 11.29 4.27 -8.69 19.09 -20.06 -22.10 30.22 Opening Cash & Equivalents 19.92 28.13 27.10 16.25 12.17 23.26 4.17 24.23 46.33 16.11 Closing Cash & Equivalent 29.88 19.92 28.13 27.10 16.25 14.56 23.26 4.17 24.23 46.33

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 90.18 82.16 72.38 71.06 60.53 52.22 47.20 43.05 37.54 33.12 ROA 10.79% 8.35% 8.82% 11.97% 14.09% 13.24% 13.27% 17.44% 16.44% 20.74% ROE 16.59% 12.73% 13.33% 15.99% 16.85% 16.50% 16.62% 21.61% 20.45% 26.22% ROCE 22.06% 17.63% 18.62% 21.45% 23.25% 22.89% 27.15% 27.59% 26.34% 30.58% Fixed Asset Turnover 1.65 1.36 1.41 1.45 1.53 1.68 1.91 1.83 1.77 1.92 Receivable days 27.76 27.18 26.29 24.69 22.54 24.73 22.57 19.99 20.59 19.27 Inventory Days 51.08 56.38 50.45 46.49 45.50 45.20 42.33 46.42 50.48 47.43 Payable days 38.45 40.30 41.31 40.79 44.71 48.03 44.04 40.19 37.05 32.64 Cash Conversion Cycle 40.39 43.27 35.43 30.39 23.32 21.90 20.86 26.22 34.02 34.06 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 96.31 166.02 167.77 178.52 167.05 115.57 73.00 134.11 129.58 130.03

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 90.51 82.86 73.17 71.42 60.87 52.62 47.47 43.30 37.95 33.35 ROA 10.48% 8.30% 9.05% 12.00% 14.01% 13.34% 13.26% 16.92% 16.41% 20.83% ROE 16.10% 12.63% 13.67% 16.02% 16.76% 16.64% 16.63% 21.01% 20.48% 26.44% ROCE 21.63% 17.64% 19.04% 21.51% 23.15% 23.02% 27.12% 26.85% 26.34% 30.73% Fixed Asset Turnover 1.66 1.37 1.42 1.44 1.52 1.65 1.87 1.79 1.75 1.91 Receivable days 27.96 28.31 26.58 23.96 22.06 24.19 21.70 19.72 20.88 19.59 Inventory Days 50.80 55.93 50.15 46.55 45.58 45.45 42.89 46.90 50.57 47.41 Payable days 38.50 40.35 41.32 40.83 44.81 47.89 44.12 40.39 37.33 32.94 Cash Conversion Cycle 40.26 43.89 35.41 29.68 22.84 21.74 20.47 26.23 34.12 34.06 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 Interest Cover 94.95 166.95 172.62 179.60 167.11 113.30 71.41 124.23 122.88 122.86

Top Investors:

reliance capital trustee co ltd-a/c

fidelity puritan trust-fidelity low

bengal finance & investment pvt. l

jayashree vivek chandavarkar

Annual Reports:

News Update:

FDC launches two variants of Favipiravir drug for Covid-19
26th Aug 2020, 09:10 AM

The company’s PiFLU and Favenza is currently available across the country.
Read More
FDC inks pact to acquire additional stake in FDC SA
8th Aug 2020, 08:53 AM

The company would be holding 93% of the equity share capital of FOCSA, whereby FOC SA would become a subsidiary of the company
Read More
FDC - Quarterly Results
7th Aug 2020, 19:08 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback